Overexpression of peroxiredoxin-3 and -5 is a potential biomarker for prognosis in endometrial cancer.
Byun JM, Kim SS, Kim KT, Kang MS, Jeong DH, Lee DS, Jung EJ, Kim YN, Han J, Song IS, Lee KB, Sung MS.
Byun JM, et al. Among authors: kim ss, kim yn, kim kt.
Oncol Lett. 2018 Apr;15(4):5111-5118. doi: 10.3892/ol.2018.7909. Epub 2018 Jan 31.
Oncol Lett. 2018.
PMID: 29541251
Free PMC article.